Suchergebnisse - "Li, Banban"

PubPharm (23)

1

PTPRC Overexpression Predicts Poor Prognosis and Correlates with Immune Cell Infiltration in Pediatric Acute Myeloid Leukemia

enthalten in: Clinical laboratory | 2022

von Guo, G. | Li, B. | Li, Q. | +2

2

MYC overexpression predicts poor prognosis and correlates with immune infiltration in chronic lymphocytic leukemia

enthalten in: ResearchSquare.com | 2022

von Guo, D. | Li, P. | Wang, Z. | +3

3

MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1)

enthalten in: Leukemia research | 2022

von Wang, Y. | Guo, D. | Li, B. | +5

4

Identification of Hub Genes and Pathways Associated with CAR-T Cell-Mediated Neurotoxicity in DLBCL

enthalten in: Clinical laboratory | 2021

von Wang, Y. | Li, B. | Wang, Z. | +5

5

MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression

enthalten in: International journal of oncology | 2021

von Sun, J. | Ma, Q. | Shu, C. | +7

6

PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway

enthalten in: Frontiers in cell and developmental biology | 2021

von Li, B. | Jia, R. | Li, W. | +10

7

Human Ratings of Writing Quality Capture Features of Syntactic Variety and Transformation in Chinese EFL Learners' Argumentative Writing

enthalten in: Frontiers in psychology | 2021

von Xue, J. | Zheng, L. | Tang, X. | +2

8

Preparation method of moxa sticks capable of improving physiques

enthalten in: Europäisches Patentamt | 2020

von PAN YUXING | WU HONGMIN | ZHANG HONGZHOU | +6

9

RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway

enthalten in: Cell death & disease | 2020

von Sun, J. | Ma, Q. | Li, B. | +12

10

The temporal dynamics of first and second language processing : ERPs to spoken words in Mandarin-English bilinguals

enthalten in: Neuropsychologia | 2020

von Xue, J. | Li, B. | Yan, R. | +4